CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Looking for exposure in the pharma sector? Here are some worthy considerations
Henil Shah

Looking for exposure in the pharma sector? Here are some worthy considerations

Pharma and healthcare sector have rewarded its investors handsomely in the couple of years. In this article we would be listing pharma funds that are worth considering.

Pharma and healthcare sector was in a downfall since 2015 which ended after five years in the year 2020 when the pandemic was hit. Though various sectors were hit badly during the pandemic, pharma and healthcare sector were heading northwards.  

 

 

 

As you might have witnessed the steep rise during the pandemic, it has ran-up quite a bit and now seems to be cooling off. However, does it still make sense to invest in it at current juncture? For this we have to look at its valuations. As Nifty Healthcare Index has limited valuation history and 17 out of 20 constituents being pharma stocks, we will be looking at the valuations of Nifty Pharma Index.  

 

 

 

 

 

Looking at the valuation metrics such as price to earnings (P/E) and price to book (P/B) ratios, the Nifty Pharma Index seems to be at an attractive valuation. Below we have listed the top pharma and healthcare funds that are worth considering.  

 

Trailing Returns (%)

1-Year

3-Year

5-Year

DSP Healthcare Fund

11.18

29.41

-

Tata India Pharma & HealthCare Fund

11.33

24.37

13.68

UTI Healthcare Fund

10.61

23.28

12.24

SBI Healthcare Opportunities Fund

8.57

22.97

10.02

Nippon India Pharma Fund

10.27

22.83

16.13

 

Previous Article Five stocks witnessing long build-up
Next Article Five stocks witnessing short build-up
Print
591 Rate this article:
4.4
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR